Skip to main content
The Lancet Regional Health: Western Pacific logoLink to The Lancet Regional Health: Western Pacific
. 2021 Aug 20;14:100259. doi: 10.1016/j.lanwpc.2021.100259

Assessing the impact of COVID-19 border restrictions on dengue transmission in Yunnan Province, China: an observational epidemiological and phylogenetic analysis

Naizhe Li 1,2,, Yun Feng 3,, Bram Vrancken 4,, Yuyang Chen 1,2, Lu Dong 2, Qiqi Yang 5, Moritz UG Kraemer 6,7,8, Oliver G Pybus 6,9, Hailin Zhang 3,, Oliver J Brady 10,11,, Huaiyu Tian 1,2,
PMCID: PMC8387751  PMID: 34528006

Summary

Background: In response to the COVID-19 pandemic, China implemented strict restrictions on cross-border travel to prevent disease importation. Yunnan, a Chinese province that borders dengue-endemic countries in Southeast Asia, experienced unprecedented reduction in dengue, from 6840 recorded cases in 2019 to 260 in 2020.

Methods: Using a combination of epidemiological and virus genomic data, collected from 2013 to 2020 in Yunnan and neighbouring countries, we conduct a series of analyses to characterise the role of virus importation in driving dengue dynamics in Yunnan and assess the association between recent international travel restrictions and the decline in dengue reported in Yunnan in 2020.

Findings: We find strong evidence that dengue incidence between 2013-2019 in Yunnan was closely linked with international importation of cases. A 0-2 month lag in incidence not explained by seasonal differences, absence of local transmission in the winter, effective reproductive numbers < 1 (as estimated independently using genetic data) and diverse cosmopolitan dengue virus phylogenies all suggest dengue is non-endemic in Yunnan. Using a multivariate statistical model we show that the substantial decline in dengue incidence observed in Yunnan in 2020 but not in neighbouring countries is closely associated with the timing of international travel restrictions, even after accounting for other environmental drivers of dengue incidence.

Interpretation: We conclude that Yunnan is a regional sink for DENV lineage movement and that border restrictions may have substantially reduced dengue burden in 2020, potentially averting thousands of cases. Targeted testing and surveillance of travelers returning from high-risk areas could help to inform public health strategies to minimise or even eliminate dengue outbreaks in non-endemic settings like southern China.

Funding: Funding for this study was provided by National Key Research and Development Program of China, Beijing Science and Technology Planning Project (Z201100005420010); Beijing Natural Science Foundation (JQ18025); Beijing Advanced Innovation Program for Land Surface Science; National Natural Science Foundation of China (82073616); Young Elite Scientist Sponsorship Program by CAST (YESS) (2018QNRC001); H.T., O.P.G. and M.U.G.K. acknowledge support from the Oxford Martin School. O.J.B was supported by a Wellcome Trust Sir Henry Wellcome Fellowship (206471/Z/17/Z).

Chinese translation of the abstract (Appendix 2)

Keywords: COVID-19 border restrictions, dengue expansion, mosquito-borne viruses, lockdown


Research in context.

Evidence before this study

We searched PubMed from up to Feb 16, 2021, without date limits or language restrictions, using the search terms “(COVID-19 OR coronavirus OR sars-cov-2) AND (lockdown OR interventions OR restriction) AND (dengue* OR DENV*)”. In addition, we searched Health Information Platform for the Americas for data cases reported in Pan American countries. We found that the impact of COVID-19 lockdowns on dengue transmission was unclear. Pakistan, Peru, Singapore, Thailand, Ecuador, Paraguay and Bolivia reported larger outbreaks in 2020. However, Bhutan, Sri Lanka and parts of Brazil and Colombia have reported lower than average dengue case counts. The studies mainly focused on dengue endemic countries and not on areas where dengue transmission is likely initiated by importation.

Added value of this study

We investigated the transmission history of DENV in Yunnan, an area that neighbours dengue-endemic countries, using detailed genomic and epidemiological data. Our results identified Yunnan as a net importer of dengue lineages and found evidence that COVID-19 border restrictions might have substantially reduced dengue incidence in non-endemic areas. This provides the first evidence to suggest that COVID-19 related restrictions can reduce dengue transmission in non-endemic areas.

Implications of all the available evidence

The impacts of travel restrictions, due to the COVID-19 pandemic, on dengue need to be characterised to inform short- and long-term plans for dengue control. Our findings show that border restrictions can mitigate dengue transmission in non-endemic areas and identify the importance of international human mobility for dengue spread.

Alt-text: Unlabelled box

Introduction

Dengue is responsible for 10,000 deaths annually1 and is responsible for the largest burden of all the arboviral diseases, with an estimated 100 million symptomatic infections per year globally.2 The number of dengue cases reported to WHO has increased over 8 fold over the last two decades, from 0.5 million in 2000, to > 2.4 million in 2010, and to 4.2 million in 20193 and it has been estimated that over 6.1 billion people might be at risk of dengue by 2080.4 Dengue virus (DENV) is a mosquito-borne virus and a member of the Flaviviridae family.5,6 Vector control and community engagement remain the main strategies to reduce dengue burden. Although the first vaccine against dengue has been licensed, its use is limited because pre-screening for serostatus is required and only those identified as seropositive individuals can receive the vaccine.7 Furthermore, increasing international movement, and thus introduction of DENV via viremic humans, has facilitated geographic expansion. Even small numbers of imported dengue cases, i.e. DENV introductions, can trigger locally acquired infections and even local outbreaks.8

In response to the COVID-19 pandemic, a series of nonpharmaceutical interventions (NPIs) have been used to control the disease spread globally.9 To avoid imported cases, China implemented strict lockdowns and immigration controls on the border ports since early 2020. Lockdowns and travel restrictions have led to substantial reductions in the burden of infections that are transmitted from human to human, such as influenza10 and measles,11 however the impact of COVID-19 lockdowns on dengue transmission remains unknown.12 Worse than average dengue incidence has so far been reported from various countries.[13], [14], [15] In contrast, China reported a substantial reduction of dengue cases in 2020 (a total of 810 cases), compared to previous years (22201 in 2019, 5117 in 2018 and 5897 in 2017).16 Yunnan Province, located at the fringe of the global distribution of dengue, across Tropic of Cancer and inside the 10°C winter isotherm,17 borders Myanmar and Laos, dengue-endemic counties in Southeast Asia, and has recently experienced its largest-recorded dengue outbreak in decades in 2019. While lockdowns in Yunnan ended in early March, international travel restrictions remained throughout 2020, presenting a unique opportunity to quantify the role of trans-border human movement in shaping dengue dynamics in southern China.

Despite international movement restrictions in 2020, some countries have reported worse than average dengue incidence. It has been hypothesised that such increases could be due to lockdowns disrupting routine vector control programs.12 More time spent at home may also increase the transmission of vector-borne diseases in settings where household-transmission predominates.18 At a city or national scale, human movement plays an important role in the spread of dengue.19 NPIs can cut down the transmission links between different areas. These protective impacts of movement restrictions will be most pronounced in non-endemic areas, such as Yunnan and studying the impact of border restrictions in such areas can give new insights into the role of international movement in the spread of dengue. In particular they can help distinguish areas that are sources (net exporters) or sinks (net importers) of DENV transmission. Targeting surveillance and quarantine measures in DENV sinks and, in particular towards travelers arriving from DENV sources could result in a large reduction in transmission.

In this study, we combine detailed genomic and epidemiological data from both imported and locally acquired dengue cases during 2013–2020 to assess the effect of border-restrictions on dengue spread. We reconstruct the dispersal history and transmission pattern of DENV in this area using phylogeographic inference. Specifically, we aim to investigate how dependent dengue dynamics in Yunnan are on international importation of DENV via infected travelers from dengue-endemic tropical countries. Our findings aim to provide new insights for dengue prevention and control.

Methods

Source of case data

Notified dengue cases in Yunnan Province between January 2013 and December 2020 were obtained from the Yunnan Center for Disease Control and Prevention (CDC). In China, dengue is a class B notifiable infectious disease and all human cases must be reported to the Chinese CDC by law. Dengue cases were confirmed according to clinical diagnosis and laboratory confirmation according to diagnostic criteria (WS 216-2008, WS216-2018) from the Ministry of Health of the People's Republic of China. An imported case of dengue fever is defined as a patient who had traveled to another country, in which dengue fever is endemic, with a bite history within 15 days prior to the onset of illness. All cases were distinguished as imported or locally acquired dengue cases. Monthly reported cases in Ruili and Jinghong, two border cities of Yunnan, were also collected from Yunnan CDC and confirmed according to the same criteria. The reported cases in Viet Nam, Laos, Thailand, and Myanmar were obtained from the WHO Regional Office for the Western Pacific's Institutional Repository for Information Sharing (WPRO IRIS, http://apps.who.int/iris/), Ministry of Public Health in Thailand (MoPH, http://www.boe.moph.go.th/boedb/surdata/index.php) and European Centre for Disease Prevention and Control (ECDC, https://www.ecdc.europa.eu/en/dengue-monthly). If a week spanned across months, we apportioned cases based on the proportion of days of the overlapping week in each month. The demographic data were collected from United Nations Demographic and Social Statistics (https://unstats.un.org/unsd/demographic-social/) and Yunnan Bureau of Statistics (http://stats.yn.gov.cn/).

Source of sequence data

A total of 243 DENV E gene sequences were obtained using serotype identification primers from patients with dengue fever in Yunnan during 2013-2017, as previously published elsewhere.[20], [21], [22] DENV (DENV-1 to DENV-4) envelope (E) gene sequences with known collection dates and locations of sampling in Asia were also collected from GenBank. The sequences dataset comprised published and available sequences, as of November 2020. The remaining strains comprised a total of 15,368 sequences sampled between 1956 and 2020, from 20 distinct countries or geographic regions. The recombinant and high similarity (>99%) strains were removed and in order to control for possible bias from uneven sampling, we randomly subsampled the complete sequence datasets by location and sampling time. At most 10 sequences were sampled per country and per year in order to create a more equitable spatio-temporal sampling distribution. We reconstructed ML trees using Fasttree23 and the clusters containing Yunnan strains were kept. The final datasets for each serotype were prepared separately and the final dataset contained 970 DENV-1 sequences, 725 DENV-2 sequences, 704 DENV-3 sequences, and 591 DENV-4 sequences. We defined 28 regions to which the taxa were allocated, including 15 countries and 13 provinces in China. Sequences were grouped by serotype and aligned separately using MAFFT.24 Recombination was inspected using the methods implemented in RDP425 and SimPlot.26

Climatic data and Vector Suitability Scores Climatic suitability scores were estimated by collating data on Aedes mosquitoes, temperature, relative humidity and precipitation. We used mean values of Ruili and Jinghong to represent Yunnan. The data from capital cities were collected to represent each country. We used monthly Aedes aegypti suitability maps at a 5km×5km spatial resolution, and then aggregated these high-resolution maps at city level in Yunnan.27,28 Meteorological data were obtained from the World Weather Online (https://www.worldweatheronline.com/).

Statistical analysis

A generalised liner model (GLM) with quasi-Poisson distribution was established to quantify the relationship between border restrictions (exposure) and dengue cases in Yunnan (outcome). Climate factors (average temperature, relative humidity, and total precipitation) with 0-3 month lags were included as potential alternative variables and a binary variable to represent border restrictions (the exposure) was included in the model. Two fixed effect variables, year and month, were also included to control long-term trend and seasonality (additional unobserved confounding). Annual ppopulation (on the log scale) was included as an offset in the model to account for changing population sizes. The variables were selected using a forward stepwise regression method and the best model was chose based on the Quasi Akaike Information Criterion (QAIC). The selected regression model was as follows:

YtQuasipoisson(denguecaset)log(denguecaset)=α+β1Temt1+β2Humt1+β3BRt+Month+Year+offset(log(pop))

dengue caset represents number of reported cases in month t. The α is the intercept. The βj’s are the regression coefficients. Temt-1 represents the average temperature in Yunnan in month t-1. Humt-1 is the relative humidity in Yunnan in month t-1. BRt is used to identify whether the border restriction is conducted in month t. BR was set to 1 between March and the end of the time series.29 We do not consider the effects of other NPIs such as stay at home orders or social distancing because human mobility data (Baidu migration flows database, http://qianxi.baidu.com/ ) suggest that human movement had already rebounded to pre-pandemic levels by mid-March, long before the usual June-November dengue season in Yunnan (Figure S10). The regression was performed using the R version 4.1.0.

In addition to the regression analysis we also assessed the regional correlation in dengue incidence between Yunnan and its neighbouring countries (each country tested independently) using Pearson's correlation coefficient on incidence values at 0-3 month lags. This was assessed separately for data 2013-2019 and for 2020 to assess the impact of border restrictions on regional synchrony in dengue incidence. This lagged correlation analysis was also repeated for climate variables.

Birth-death skyline analyses

To analyse the transmission dynamics of DENV in Yunnan, the birth-death skyline model implemented within BEAST2 was used.30 We used sequences from Yunnan and the total number of sequences analysed here was 138 for DENV-1, 107 for DENV-2, 125 for DENV-3, and 30 for DENV-4. A log-normal prior with a mean value (M) of 0.0 and a variance (S) of 1 was specified for the effective reproductive number (R). For the recovery rate, a log-normal prior with M = 3 and S = 0.5 (95% confidence interval 8.82-45.7, corresponding to an infectious period of between 8.0 and 41.3 days) was used. The sampling probability was estimated using a uniform (beta (1.0, 1.0)) prior. The origin of the epidemic was estimated by means of a log-normal prior with M = 3 and S = 0.5. The MCMC analyses were run for 50 million generations, sampling every 5,000 steps. Convergence was assessed based on ESS values (ESS >200). Uncertainty in the estimates was indicated by 95% highest posterior density (95% HPD) intervals.

Molecular clock and phylogeographic analyses

For each serotype subsampled data set, we first evaluated the strength of the temporal signal using TempEst.31 This revealed a strong and positive correlation between genetic divergence and sampling time for each data set (r = 0.75 for DENV-1; r = 0.84 for DENV-2; r = 0.87 for DENV-3; r = 0.76 for DENV-4). Time-stamped phylogenies were estimated using the Bayesian MCMC approach implemented in BEAST v1.10.4.32 For each serotype, three independent Markov chain Monte Carlo (MCMC) chains were computed for 500 million steps, sampling every 50,000 steps after the removal of 10% burn-in. An uncorrelated lognormal relaxed molecular clock model33 and a coalescent-based tree topology prior with Gaussian Markov random field (GMRF) based time-aware smoothing were used.34 The tree prior describes how the population size is expected to change over time. Using a skyride model, we assumed a smooth process on population size changes. The substitution process describes changes in the rate of molecular evolution and was modelled as a GTR+I+Γ process. A non-informative continuous-time Markov chain (CTMC) reference prior35 was specified on the mean clock rate. The BEAGLE library was used to accelerate computation.36 Analyses were combined after discarding the first 10% of the chain as burn-in, and convergence and mixing properties were evaluated with Tracer v1.7.37 A total of 10,000 trees was generated from the MCMC chain and used as an empirical tree distribution for the subsequent phylogeographic reconstructions.

To reconstruct the spatial dynamics of DENV-1–4, we conducted phylogeographic analyses to infer ancestral branch locations using the Bayesian asymmetric discrete trait evolution model, 38 as implemented in BEAST v1.10.4.32 For each serotype, support for non-zero rates of exchange between all pairs of locations was evaluated using Bayesian stochastic search variable selection (BSSVS). Maximum clade credibility (MCC) trees were summarised using TreeAnnotator and visualised using SPREAD3 from the posterior distribution of trees.39 Estimates of the posterior expected number of migration events between all pairs of locations (Markov jumps) were computed through stochastic mapping techniques.34,40

Role of the funding source

The funders had no role in study design, data collection and analysis, the decision to publish, or in preparation of the manuscript.

Results

Declining dengue incidence in Yunnan in 2020 is associated with border restrictions

During 2013–2019, more than 15000 dengue cases were reported in Yunnan with a peak in 2019 (Fig. 1A). The year 2020 has seen a substantial reduction relative to this historical trend with a decline from 6840 reported dengue cases in 2019 to 260 in 2020, whereas there was no obvious reduction relative to the historical average in the bordering countries (Fig. 1B). Compared with the average annual incidence during 2013-2019, dengue incidence in 2020 reduced by 88.4% in Yunnan, 54.8% in Laos, 27.2% in Thailand and 11.6% in Viet Nam. The number of reported cases in bordered countries were notably higher than Yunnan in 2020 (Fig. 1C). Compared to 2016, the last year with a dengue outbreak in neighbouring countries of comparable size to 2020(Table S3), the number of cases in Yunnan had reduced by 50.5% (260 vs. 525).

Fig. 1.

Fig 1

Border restriction and dengue transmission dynamics in areas in China-Myanmar-Laos border, 2013-2020. (A) Annual number of total reported cases and imported cases in Yunnan, China. The vertical line is the start of Yunnan border restriction. Black line, total reported cases; orange line, imported cases. (B) Monthly dengue incidence in Yunnan and near by countries. (C) China-Myanmar-Laos border. Point size represents the number of dengue cases in 2020. Dotted line is the Tropic of Cancer, 23.5 degrees north of the equator, and 10°C January isotherm, respectively. (D) Proportion of seasonal imported (blue), locally acquired (orange) and monthly average of dengue cases (black line) in Yunnan, 2013–2020.

Noted: Epidemiological data of Myanmar used in panel C was collected as of July, 2020. Data used in panel D was collected from Ruili and Jinghong.

To assess whether the 2020 reduction in Yunnan could be explained by dengue inter or intra-annual trends or abnormal weather conditions, we fit a generalised linear model that includes temperature, rainfall and relative humidity and temporal effects in addition to border restrictions. The “border restriction” variable was retained in model selection procedures and a significant negative association with dengue incidence in Yunnan was found (coefficient = -2.96, P < 0.01, Table S6). The model predicted 4774 reported cases if border restrictions were not conducted compared to 249 in the presence of border restrictions (risk ratio of 19.2, observed cases: 260).

To further investigate the usual dengue season synchrony between Yunnan and neighbouring countries we examine data in two border cities of Yunnan, Ruili and Jinghong where monthly dengue case data were available. Considering Ruili and Jinghong were the most affected cities and reported 86% of locally acquired cases and 73% of total dengue cases during 2013-2020 in Yunnan, we assumed the data were representative of wider dengue dynamics in Yunnan. We found that between 2013 and 2019 monthly dengue incidence in Yunnan is correlated with dengue incidence in border countries with a 0-2 month lag (Pearson r = 0.59, P < 0.01, 2-month lag with Laos; Pearson r = 0.57, P < 0.01, 2-month lag with Thailand; Pearson r = 0.54, P < 0.01, 0-month lag with Viet Nam). To see if this lag was solely due to lagged environmental drivers of DENV transmission, we analysed the correlation of the climate factors between Yunnan and border countries. We found 1-month lagged peak correlation in humidity but no lagged correlation in temperature and precipitation (Fig S3, Table S7). This means that the 0-2 month lag between elevated dengue incidence in Yunnan and its neighbouring countries is unlikely to be explained by lags in climate alone and more likely involves delayed introduction then spread of the epidemic within Yunnan. In the year 2020 this regional synchrony was not present with no evidence of significant correlation with dengue dynamics in Thailand or Laos and only moderate correlation with Viet Nam (Pearson r = 0.58, P < 0.05). We were unable to assess the correlation between dengue cases in Yunnan with those in Myanmar in 2020 as data was not available form this country at the time of analysis.

Combined, these analyses show that Yunnan has seen a much bigger decline and disruption of dengue dynamics in 2020 than its regional neighbours and that this decline is significantly associated with the timing of border restrictions.

Characterizing the role of dengue importation in shaping dengue dynamics in Yunnan 2013-2019

To further understand why border restrictions had such a large impact on dengue dynamics in Yunnan we also analyse epidemiological and genomic data from the years 2013-2019 to show how case importation and seasonality play a critical role in dengue dynamics in Yunnan.

Historically, there has been a close correlation between the annual number of imported cases and the total number of cases in Yunnan (Fig. 1A, Pearson r = 0.88, P < 0.01). Overall, the number of locally acquired cases was far higher than imported cases, with a proportion of 69.2%. Imported cases were reported all year round but outbreaks of local transmission were restricted to summer periods (June-December, Fig. 1D). Combined these epidemiological data sources suggest that transmission does not persist through the winter, but is re-introduced seasonally and that the size of that re-introduction, along with environmental factors that affect Aedes mosquito population dynamics, likely determine the size of the epidemic.

We used Bayesian birth-death skyline analysis (BDSKY)41 to estimate the effective reproductive number (Re) from the DENV sequences in Yunnan. Re is defined as the average number of secondary infections caused by a single infectious person over the course of their infection (Re > 1 and Re < 1 represents epidemic growth and decline, respectively). Although DENV introduction events occurred year-round (Fig. 2A), we observed a clear seasonal pattern of epidemic growth (Fig. 2B), Re > 1 between June and November, which coincided with the timing of local transmission in the epidemiological data (Fig. 1D). While at least one serotype had estimates of Re > 1 within this summer transmission window each year, not every serotype was capable of epidemic growth every year (e.g. only DENV 1 in 2016 and 2018). This may suggest that despite relatively low transmission levels relative to bordering countries, DENV selection due to population immunity may still be occurring in Yunnan. Estimated Re values for Yunnan also showed close correlation with temperature, humidity, precipitation (Fig. 2C, 2D) and mosquito suitability (Fig S4, Table S8). These correlations were robust to uncertainty in effective reproduction number estimation findings (Fig. S5, Table S9). This provides further evidence that dengue transmission is unsustainable over the winter months in Yunnan and that these unsuitable periods are due to unfavorable weather conditions which is consistent with our theoretical and observational understanding of how climate affects global dengue dynamics27,[42], [43], [44]

Fig. 2.

Fig 2

Genomic epidemiology of DENV and climatic variables in Yunnan. (A) The inferred time of the most recent common ancestor (TMRCA) of DENV-1 (green), DENV-2 (orange), DENV-3 (purple) and DENV-4 (black) introduction to Yunnan. The points represent the mean date and the dotted lines show the 95% highest posterior density. (B) Time-varying effective reproductive numbers (Re), estimated using a birth–death skyline approach. Solid line represents the median posterior estimate of Re for each DENV type. Insufficient DENV-4 sequences were available to include in this analysis. (C) Mean temperature of Ruili and Jinghong. (D) Mean relative humidity and precipitation of Ruili and Jinghong.

We used a Bayesian phylogeographic approach to reconstruct the origins and spread of DENV in Yunnan and bordering countries prior to 2020 to understand what role Yunnan normally plays in regional dengue dynamics. We find that the viruses in Yunnan were widely distributed across the phylogenetic tree and most of them clustered with viruses isolated from nearby areas (Fig. 3, Fig. S6-8). Rare continuous evolution of DENV in Yunnan over time indicated that Yunnan remained a non-endemic area and that local infections are more likely to result from imported cases.

Fig. 3.

Fig 3

Sources of dengue virus introduction at China-Myanmar-Laos border. The upper panel shows the maximum clade credibility trees of the E gene of DENV-1 (n=970). Branches and tips are colored according to Yunnan (orange), the border areas of Yunnan (green) and other areas (purple). The inset shows a root-to-tip regression of genetic divergence against dates of sample collection. The lower panel shows the estimated flows (number of expected transitions summed by DENV serotype) into (left to central) and from (central to right) Yunnan.

Our results further indicate a high frequency of virus lineage migration among Yunnan and border countries (Fig. 3). Laos and Myanmar were major foreign sources of DENV in Yunnan. For DENV-1 and DENV-2, the virus is estimated to be mainly imported from Myanmar and other areas of China. Despite having lower incidence than bordering countries and lagged epidemics, Yunnan was still a significant exporter of DENV lineages. Significant links from Yunnan to Myanmar, Thailand and other areas of China were found. Notably, DENV-2 showed more exportation than importation events, which was unique among the 4 serotypes Fig. S9). No evidence of DENV-3 migration was found between Myanmar and Yunnan, but neighbouring Laos was identified as an important foreign source of DENV-3 for Yunnan. For DENV-4, on the other hand, Myanmar was the almost exclusive source. However, due to data availability and undersampling of DENV genomes, we cannot rule out other source areas. These results suggest that international spread plays an important role in regional dengue dynamics and that even non-endemic areas repeatedly export DENVs that initiate transmission in other endemic and non-endemic areas.

Discussion

Using a combination of epidemiological and phylogenetic data we show that DENV transmission in Yunnan is only made possible by frequent re-introduction. By showing that (i) there are no locally-acquired cases during the winter, (ii) local epidemics consistently are preceded by those in neighbouring areas despite similar climates, (iii) that the size of local epidemic correlates with the number of imported cases, (iv) Re (as estimated by independent genomic data) is consistently below 1 throughout the winter and (v) intermixing of locally acquired DENV sequences among those from neighbouring countries in the phylogenies, we provide the most comprehensive collection of evidence to date that Yunnan is a sink of DENV transmission. These findings combined with the close correlation between border restrictions and the unexpectedly low levels of dengue in Yunnan in 2020 lead us to conclude that international travel restrictions reduce dengue risk in non-endemic areas such as Yunnan.

Despite Yunnan experiencing only lower-incidence, seasonal transmission driven by imported cases, it is still able to export a significant number of DENV lineages, both domestically and internationally (Table S10). Furthermore, variations in serotype-specific Re may suggest that immune-driven selection of DENVs may still be occurring even in this low transmission intensity environment. This suggests that non-endemic dengue sinks may still play an important role in international DENV spread dynamics.

The current international travel restrictions present a unique opportunity to measure the contribution of international travel to dengue source and sink dynamics and understanding the global expansion of dengue. Our results illustrate that border restrictions were strongly associated with dengue mitigation in non-endemic areas and likely caused the reduction of dengue incidence in Yunnan. Due to the environmental continuity and close cultural, historical and linguistic ties, cross-border movement and trade between Yunnan and neighbouring countries is common.45 Previous studies have hypothesised that dengue expansion is driven by human movement[46], [47], [48] and that cross-border population movement creates great challenges for preventing the international spread of infectious diseases.[49], [50], [51], [52] While travel restrictions impose significant economic and societal impacts and are unlikely to be a proportionate tool to prevent the spread of dengue, these results do suggest a potential greater role for dengue surveillance and quarantine policies for travelers arriving from endemic countries during large outbreaks or high risk dengue seasons. Further work is needed to understand the broader implications of such policies on long-term DENV dynamics as well as other diseases whilewhi simultaneously considering their adverse societal impacts.

It has been suggested that climate plays a strong role in limiting the global distribution of dengue and that climate change may facilitate future dengue expansion.4 Located within 10°C January isotherm and neighbouring the Tropic of Cancer, Yunnan is at risk of transitioning to an endemic region as aresult of itioning global warming. But our analysis shows that Yunnan still remains a non-endemic dengue setting at the edge of the distribution of dengue in Asia. The Re and epidemiological surveillance show that local transmission in Yunnan consistently occurs year-to-year, but only in warmer months and that dengue expansion in Yunnan is more closely associated with movement of infected humans. This suggests that future projections of the global distribution of dengue need to take into account human movement, particularly in environments that are only suitable seasonally.

Our study has several limitations. First, ideally more information on international human movement among the population and among dengue cases would be available. Even aggregate data on human transboundary movements, or the number of passengers arriving from specific destinations over time, would help disentangle the relative role of different countries in DENV spread.

Second, while we attempted to adjust for alternative variables when statistically testing the association between border restrictions and dengue incidence, immunity and underreporting could potentially introduce unmeasured confounding. Like in many other countries worldwide, the year 2019 saw exceptionally high dengue incidence in Yunnan (Fig. 1B) and immunity may have contributed to the observed decline in 2020 and hence led us to overestimate the effects of border closures. However, many countries in South East Asia also observed large dengue outbreaks in 2019 yet did not see declines in 2020 dengue incidence to the extent of that observed in Yunnan. There may also be concerns that COVID-19 related disruption may have led to underreporting of dengue cases which was not included in our analysis. While this remains to be seen, it would only affect our findings of an association if underreporting was substantially worse in Yunnan compared to neighbouring countries. Given COVID-19 lockdown restrictions in China were among the briefest in the region and only occurred outside the usual dengue season, it would be surprising if impacts on dengue surveillance in Yunnan in 2020 were greater than in neighbouring countries.

Third, because virus samples can only be extracted from a small handful of DENV infections, the extent of viral migration is an underestimation of the true frequency. This is likely more pronounced for more recent time periods due to the low case number in 2020 and data reporting lags. While underestimation of the importation frequency can be countered by prioritizing the sequencing of cases that are likely imported based on travel history, this strategy can not compensate for undersampling the virus diversity in the source regions.53 As transmission chains are inferred based on sequence data, undersampling also makes it difficult to conclusively distinguish between local and repeatedly introduced transmission chains. Continued monitoring of dengue infection trends in Yunnan in the period following the end of (cross-border) mobility restrictions will be important to monitor as absence of transmission in 2020 will lead to lower levels of immunity and possibly higher outbreak risk once international travel resumes.

Declaration of Competing Interest

The authors declare no competing interests.

Acknowledgments

Author contributions

H.T. designed the study. Y.F., Y.C., L.D., Q.Y., and H.Z., collected the statistical data. N. L. and H. T. draw the figures. N.L., B.V. conducted the analyses. B.V., M.U.G.K., O.G.P., O.J.B., H.T. edited the manuscript. N.L., H.T wrote the manuscript. All authors read and approved the manuscript.

Acknowledgements

Funding for this study was provided by National Key Research and Development Program of China, Beijing Science and Technology Planning Project (Z201100005420010); Beijing Natural Science Foundation (JQ18025); Beijing Advanced Innovation Program for Land Surface Science; National Natural Science Foundation of China (82073616); Young Elite Scientist Sponsorship Program by CAST (YESS) (2018QNRC001); H.T., O.G.P., and M.U.G.K. acknowledge support from the Oxford Martin School. The funders had no role in study design, data collection and analysis, the decision to publish, or in preparation of the manuscript.

Data sharing statement

We analysed the DENV genomic data from GenBank. Standard R-packages were used to produce results for this analysis. No custom code was developed. R code and XML files used for this study are available on GitHub (https://github.com/lnzh330/Yunnan-Dengue-BR).

Editor note: The Lancet Group takes a neutral position with respect to territorial claims in published maps and institutional affiliations.

Footnotes

Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.lanwpc.2021.100259.

Appendix. Supplementary materials

mmc1.docx (2.9MB, docx)
mmc2.docx (18.5KB, docx)
mmc3.docx (15.9KB, docx)

References

  • 1.Stanaway JD, Shepard DS, Undurraga EA. The global burden of dengue: an analysis from the Global Burden of Disease Study. Lancet Infect Dis. 2013;16(6):712–723. doi: 10.1016/S1473-3099(16)00026-8. 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Messina JP, Brady OJ, Pigott DM, Brownstein JS, Hoen AG, Hay SI. A global compendium of human dengue virus occurrence. Sci Data. 2014;1 doi: 10.1038/sdata.2014.4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.WHO. Dengue and severe dengue. https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue (accessed 23 November 2020).
  • 4.Messina JP, Brady OJ, Golding N. The current and future global distribution and population at risk of dengue. Nat Microbiol. 2019;4(9):1508–1515. doi: 10.1038/s41564-019-0476-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Gubler DJ, Clark GG. Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg Infect Dis. 1995;1(2):55–57. doi: 10.3201/eid0102.952004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Twiddy SS, Holmes EC, Rambaut A. Inferring the rate and time-scale of dengue virus evolution. Mol Biol Evol. 2003;20(1):122–129. doi: 10.1093/molbev/msg010. [DOI] [PubMed] [Google Scholar]
  • 7.Bonaparte M, Zheng L, Garg S. Evaluation of rapid diagnostic tests and conventional enzyme-linked immunosorbent assays to determine prior dengue infection. J Travel Med. 2019;26(8) doi: 10.1093/jtm/taz078. taz078. [DOI] [PubMed] [Google Scholar]
  • 8.Messina JP, Brady OJ, Pigott DM. The many projected futures of dengue. Nat Rev Microbiol. 2015;13(4):230–239. doi: 10.1038/nrmicro3430. [DOI] [PubMed] [Google Scholar]
  • 9.Lemey P, Hong SL, Hill V. Accommodating individual travel history and unsampled diversity in Bayesian phylogeographic inference of SARS-CoV-2. Nat Commun. 2020;11(1):5110. doi: 10.1038/s41467-020-18877-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Cowling BJ, Ali ST, Ng TWY. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health. 2020;5(5):e279–ee88. doi: 10.1016/S2468-2667(20)30090-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Nicolay N, Mirinaviciute G, Mollet T, Celentano LP, Bacci S. Epidemiology of measles during the COVID-19 pandemic, a description of the surveillance data, 29 EU/EEA countries and the United Kingdom. Euro Surveill. 2020;25(31) doi: 10.2807/1560-7917.ES.2020.25.31.2001390. January to May 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Brady O, Wilder-Smith A. What Is the Impact of Lockdowns on Dengue? Curr Infect Dis Rep. 2021;23(2) doi: 10.1007/s11908-020-00744-9. 2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Rana MS, Alam MM, Ikram A, Zaidi SSZ, Salman M, Khurshid A. Cocirculation of COVID-19 and dengue: A perspective from Pakistan. J Med Virol. 2020;93(3) doi: 10.1002/jmv.26567. 2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Lam LTM, Chua YX, Tan DHY. Roles and challenges of primary care physicians facing a dual outbreak of COVID-19 and dengue in Singapore. Fam Pract. 2020;37(4):578–579. doi: 10.1093/fampra/cmaa047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lim JT, Dickens BSL, Chew LZX. Impact of sars-cov-2 interventions on dengue transmission. PLoS Negl Trop Dis. 2020;14(10) doi: 10.1371/journal.pntd.0008719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Division of Infectious Disease of China CDC. National Data of Class A, B and C Communicable Diseases in December 2020. Disease Surveillance. 2021;36(1):1. [Google Scholar]
  • 17.Jansen CC, Beebe NW. The dengue vector Aedes aegypti: what comes next. Microbes Infect. 2010;12(4):272–279. doi: 10.1016/j.micinf.2009.12.011. [DOI] [PubMed] [Google Scholar]
  • 18.Stoddard ST, Morrison AC, Vazquez-Prokopec GM. The role of human movement in the transmission of vector-borne pathogens. PLoS Negl Trop Dis. 2009;3(7):e481. doi: 10.1371/journal.pntd.0000481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Tian H, Sun Z, Faria NR. Increasing airline travel may facilitate co-circulation of multiple dengue virus serotypes in Asia. PLoS Negl Trop Dis. 2017;11(8) doi: 10.1371/journal.pntd.0005694. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hu TS, Zhang HL, Feng Y. Epidemiological and molecular characteristics of emergent dengue virus in Yunnan Province near the China-Myanmar-Laos border, 2013-2015. BMC Infect Dis. 2017;17(1):331. doi: 10.1186/s12879-017-2401-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Fan JH, Feng Y, Zhu J. An outbreak of dengue serotype 1 virus in Xishuangbanna prefecture of Yunnan province, China, 2017. Disease Surveillance. 2019;34(5):427–434. [Google Scholar]
  • 22.Feng Y, Zhang HL, Pan H. Diversity of serotypes and genotypes and molecular tracing of dengue viruses isolated from dengue fever cases in Yunnan. Chin J Exp Clin Virol. 2017;31(1):24–30. [Google Scholar]
  • 23.Price MN, Dehal PS, Arkin AP. FastTree 2–approximately maximum-likelihood trees for large alignments. PLoS One. 2010;5(3):e9490. doi: 10.1371/journal.pone.0009490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Katoh K, Standley DM. MAFFT multiple sequence alignment software version 7: improvements in performance and usability. Mol Biol Evol. 2013;30(4):772–780. doi: 10.1093/molbev/mst010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Martin DP, Murrell B, Golden M, Khoosal A, Muhire B. RDP4: Detection and analysis of recombination patterns in virus genomes. Virus Evol. 2015;1(1):vev003. doi: 10.1093/ve/vev003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Lole KS, Bollinger RC, Paranjape RS. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol. 1999;73(1):152–160. doi: 10.1128/jvi.73.1.152-160.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kraemer MU, Sinka ME, Duda KA. The global compendium of Aedes aegypti and Ae. albopictus occurrence. Sci Data. 2015;2 doi: 10.1038/sdata.2015.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Faria NR, Quick J, Claro IM. Establishment and cryptic transmission of Zika virus in Brazil and the Americas. Nature. 2017;546(7658):406–410. doi: 10.1038/nature22401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Sina. Quanratine all import passengers. http://k.sina.com.cn/article_6456450127_180d59c4f02000wrsc.html?from=news&subch=onews (accessed 22 March 2020).
  • 30.Bouckaert R, Vaughan TG, Barido-Sottani J. BEAST 2.5: An advanced software platform for Bayesian evolutionary analysis. PLoS Comput Biol. 2019;15(4) doi: 10.1371/journal.pcbi.1006650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Rambaut A, Lam TT, Max Carvalho L, Pybus OG. Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen) Virus Evol. 2016;2(1):vew007. doi: 10.1093/ve/vew007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Drummond AJ, Suchard MA, Xie D, Rambaut A. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol Biol Evol. 2012;29(8):1969–1973. doi: 10.1093/molbev/mss075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Drummond AJ, Ho SY, Phillips MJ, Rambaut A. Relaxed phylogenetics and dating with confidence. PLoS Biol. 2006;4(5):e88. doi: 10.1371/journal.pbio.0040088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Minin VN, Suchard MA. Counting labeled transitions in continuous-time Markov models of evolution. J Math Biol. 2008;56(3):391–412. doi: 10.1007/s00285-007-0120-8. [DOI] [PubMed] [Google Scholar]
  • 35.Ferreira MAR, Suchard MA. Bayesian analysis of elapsed times in continuous-time Markov chains. CAN J STAT. 2008;36(3):355–368. [Google Scholar]
  • 36.Suchard MA, Rambaut A. Many-core algorithms for statistical phylogenetics. Bioinformatics. 2009;25(11):1370–1376. doi: 10.1093/bioinformatics/btp244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Rambaut A, Drummond AJ, Xie D, Baele G, Suchard MA. Posterior Summarization in Bayesian Phylogenetics Using Tracer 1.7. Syst Biol. 2018;67(5):901–904. doi: 10.1093/sysbio/syy032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Lemey P, Rambaut A, Drummond AJ, Suchard MA. Bayesian phylogeography finds its roots. PLoS Comput Biol. 2009;5(9) doi: 10.1371/journal.pcbi.1000520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Bielejec F, Baele G, Vrancken B, Suchard MA, Rambaut A, SpreaD3 Lemey P. Interactive Visualization of Spatiotemporal History and Trait Evolutionary Processes. Mol Biol Evol. 2016;33(8):2167–2169. doi: 10.1093/molbev/msw082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Minin VN, Suchard MA. Fast, accurate and simulation-free stochastic mapping. Philos Trans R Soc Lond B Biol Sci. 2008;363:3985–3995. doi: 10.1098/rstb.2008.0176. 1512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Stadler T, Kühnert D, Bonhoeffer S, Drummond AJ. Birth-death skyline plot reveals temporal changes of epidemic spread in HIV and hepatitis C virus (HCV) Proc Natl Acad Sci U S A. 2013;110(1):228–233. doi: 10.1073/pnas.1207965110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Kraemer MUG, Reiner RC, Brady OJ. Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus. Nat Microbiol. 2019;4(5):854–863. doi: 10.1038/s41564-019-0376-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Brady OJ, Johansson MA, Guerra CA. Modelling adult Aedes aegypti and Aedes albopictus survival at different temperatures in laboratory and field settings. Parasit Vectors. 2013;6(1):351. doi: 10.1186/1756-3305-6-351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Scott TW, Morrison AC. Vector dynamics and transmission of dengue virus: implications for dengue surveillance and prevention strategies: vector dynamics and dengue prevention. Curr Top Microbiol Immunol. 2010;338:115–128. doi: 10.1007/978-3-642-02215-9_9. [DOI] [PubMed] [Google Scholar]
  • 45.Jiang L, Huang T. Comparison of the epidemiological aspects of acute infectious diseases between foreign and native imported cases in the border counties of Southwest China, 2008-2017. Epidemiol Infect. 2019;147:e230. doi: 10.1017/S0950268819001195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Reiner RC, Stoddard ST, Scott TW. Socially structured human movement shapes dengue transmission despite the diffusive effect of mosquito dispersal. Epidemics. 2014;6:30–36. doi: 10.1016/j.epidem.2013.12.003. Jr. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Satoto TBT, Listyantanto A, Agustjahjani SD, Josef HK, Widartono BS. Vertical transmission of dengue virus in the Yogyakarta airport area. Environ Health Prev Med. 2018;23(1):22. doi: 10.1186/s12199-018-0711-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Guzzetta G, Marques-Toledo CA, Rosà R, Teixeira M, Merler S. Quantifying the spatial spread of dengue in a non-endemic Brazilian metropolis via transmission chain reconstruction. Nat Commun. 2018;9(1):2837. doi: 10.1038/s41467-018-05230-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Pérez AB, Vrancken B, Chueca N. Increasing importance of European lineages in seeding the hepatitis C virus subtype 1a epidemic in Spain. Euro Surveill. 2019;24(9) doi: 10.2807/1560-7917.ES.2019.24.9.1800227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Al-Qahtani AA, Baele G, Khalaf N. The epidemic dynamics of hepatitis C virus subtypes 4a and 4d in Saudi Arabia. Sci Rep. 2017;7(1):44947. doi: 10.1038/srep44947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Faye O, Monteiro M, Vrancken B. Genomic Epidemiology of 2015-2016 Zika Virus Outbreak in Cape Verde. Emerg Infect Dis. 2020;26:1084–1090. doi: 10.3201/eid2606.190928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Vrancken B, Mehta SR, Ávila-Ríos S. Dynamics and Dispersal of Local HIV Epidemics Within San Diego and Across The San Diego-Tijuana Border. Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa1588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Grubaugh ND, Ladner JT, Kraemer MUG. Genomic epidemiology reveals multiple introductions of Zika virus into the United States. Nature. 2017;546(7658):401–405. doi: 10.1038/nature22400. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

mmc1.docx (2.9MB, docx)
mmc2.docx (18.5KB, docx)
mmc3.docx (15.9KB, docx)

Articles from The Lancet Regional Health: Western Pacific are provided here courtesy of Elsevier

RESOURCES